A point mutation in the ubiquitin-associated domain of SQSMT1 is sufficient to cause a Paget's disease-like disorder in mice

Anna Daroszewska, Robert J. van 't Hof, Javier A. Rojas, Robert Layfield, Euphemie Landao-Basonga, Lorraine Rose, Ken Rose, Stuart H. Ralston

Research output: Contribution to journalArticle

73 Citations (Scopus)

Abstract

Mutations of SQSTM1 occur in about 10% of patients with Paget's disease of bone (PDB), but it is unclear whether they play a causal role or regulate susceptibility to an environmental trigger. Here we show that mice with a proline to leucine mutation at codon 394 of mouse sqstm1 (P394L), equivalent to the P392L SQSTM1 mutation in humans, develop a bone disorder with remarkable similarity to PDB. The P394L mutant mice developed focal bone lesions with increasing age and by 12 months, 14/18 (77%) heterozygotes and 20/21 (95%) homozygotes had lesions, compared with 0/18 (0%) wild-type littermates (P < 0.001). Lesions predominantly affected the lower limbs in an asymmetric manner and were characterized by focal increases in bone turnover, with increased bone resorption and formation, disruption of the normal bone architecture and accumulation of woven bone. Osteoclasts within lesions were larger and more nucleated than normal and some contained nuclear inclusions similar to those observed in human PDB. Osteoclast precursors from P394L mutant mice had increased sensitivity to RANKL in vitro resulting in the generation of osteoclasts that were larger and more nucleated than those generated from wild-type littermates. There was increased expression of sqstm1, autophagy-related gene 5 (atg5) and light chain 3 gene (lc3) in osteoclast precursors and increased LC3-II protein levels in Bafilomycin-treated osteoclasts from P394L mutant mice compared with wild-type suggesting dysregulation of autophagy and enhanced autophagosome formation. These studies demonstrate that SQSTM1 mutations can cause a PDB-like skeletal disorder in the absence of an additional trigger and provide a new disease model for PDB.

Original languageEnglish
Article numberddr172
Pages (from-to)2734-2744
Number of pages11
JournalHuman Molecular Genetics
Volume20
Issue number14
DOIs
Publication statusPublished - Jul 2011
Externally publishedYes

Fingerprint

Osteitis Deformans
Osteoclasts
Ubiquitin
Point Mutation
Bone and Bones
Mutation
Autophagy
Intranuclear Inclusion Bodies
Bone Remodeling
Homozygote
Heterozygote
Bone Resorption
Proline
Osteogenesis
Codon
Leucine
Genes
Lower Extremity
Light
Proteins

Cite this

Daroszewska, Anna ; van 't Hof, Robert J. ; Rojas, Javier A. ; Layfield, Robert ; Landao-Basonga, Euphemie ; Rose, Lorraine ; Rose, Ken ; Ralston, Stuart H. / A point mutation in the ubiquitin-associated domain of SQSMT1 is sufficient to cause a Paget's disease-like disorder in mice. In: Human Molecular Genetics. 2011 ; Vol. 20, No. 14. pp. 2734-2744.
@article{10e2a34ffc944ee2af00d3176371bf32,
title = "A point mutation in the ubiquitin-associated domain of SQSMT1 is sufficient to cause a Paget's disease-like disorder in mice",
abstract = "Mutations of SQSTM1 occur in about 10{\%} of patients with Paget's disease of bone (PDB), but it is unclear whether they play a causal role or regulate susceptibility to an environmental trigger. Here we show that mice with a proline to leucine mutation at codon 394 of mouse sqstm1 (P394L), equivalent to the P392L SQSTM1 mutation in humans, develop a bone disorder with remarkable similarity to PDB. The P394L mutant mice developed focal bone lesions with increasing age and by 12 months, 14/18 (77{\%}) heterozygotes and 20/21 (95{\%}) homozygotes had lesions, compared with 0/18 (0{\%}) wild-type littermates (P < 0.001). Lesions predominantly affected the lower limbs in an asymmetric manner and were characterized by focal increases in bone turnover, with increased bone resorption and formation, disruption of the normal bone architecture and accumulation of woven bone. Osteoclasts within lesions were larger and more nucleated than normal and some contained nuclear inclusions similar to those observed in human PDB. Osteoclast precursors from P394L mutant mice had increased sensitivity to RANKL in vitro resulting in the generation of osteoclasts that were larger and more nucleated than those generated from wild-type littermates. There was increased expression of sqstm1, autophagy-related gene 5 (atg5) and light chain 3 gene (lc3) in osteoclast precursors and increased LC3-II protein levels in Bafilomycin-treated osteoclasts from P394L mutant mice compared with wild-type suggesting dysregulation of autophagy and enhanced autophagosome formation. These studies demonstrate that SQSTM1 mutations can cause a PDB-like skeletal disorder in the absence of an additional trigger and provide a new disease model for PDB.",
author = "Anna Daroszewska and {van 't Hof}, {Robert J.} and Rojas, {Javier A.} and Robert Layfield and Euphemie Landao-Basonga and Lorraine Rose and Ken Rose and Ralston, {Stuart H.}",
year = "2011",
month = "7",
doi = "10.1093/hmg/ddr172",
language = "English",
volume = "20",
pages = "2734--2744",
journal = "Human Molecular Genetics",
issn = "0964-6906",
publisher = "OXFORD UNIV PRESS UNITED KINGDOM",
number = "14",

}

Daroszewska, A, van 't Hof, RJ, Rojas, JA, Layfield, R, Landao-Basonga, E, Rose, L, Rose, K & Ralston, SH 2011, 'A point mutation in the ubiquitin-associated domain of SQSMT1 is sufficient to cause a Paget's disease-like disorder in mice' Human Molecular Genetics, vol. 20, no. 14, ddr172, pp. 2734-2744. https://doi.org/10.1093/hmg/ddr172

A point mutation in the ubiquitin-associated domain of SQSMT1 is sufficient to cause a Paget's disease-like disorder in mice. / Daroszewska, Anna; van 't Hof, Robert J.; Rojas, Javier A.; Layfield, Robert; Landao-Basonga, Euphemie; Rose, Lorraine; Rose, Ken; Ralston, Stuart H.

In: Human Molecular Genetics, Vol. 20, No. 14, ddr172, 07.2011, p. 2734-2744.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A point mutation in the ubiquitin-associated domain of SQSMT1 is sufficient to cause a Paget's disease-like disorder in mice

AU - Daroszewska, Anna

AU - van 't Hof, Robert J.

AU - Rojas, Javier A.

AU - Layfield, Robert

AU - Landao-Basonga, Euphemie

AU - Rose, Lorraine

AU - Rose, Ken

AU - Ralston, Stuart H.

PY - 2011/7

Y1 - 2011/7

N2 - Mutations of SQSTM1 occur in about 10% of patients with Paget's disease of bone (PDB), but it is unclear whether they play a causal role or regulate susceptibility to an environmental trigger. Here we show that mice with a proline to leucine mutation at codon 394 of mouse sqstm1 (P394L), equivalent to the P392L SQSTM1 mutation in humans, develop a bone disorder with remarkable similarity to PDB. The P394L mutant mice developed focal bone lesions with increasing age and by 12 months, 14/18 (77%) heterozygotes and 20/21 (95%) homozygotes had lesions, compared with 0/18 (0%) wild-type littermates (P < 0.001). Lesions predominantly affected the lower limbs in an asymmetric manner and were characterized by focal increases in bone turnover, with increased bone resorption and formation, disruption of the normal bone architecture and accumulation of woven bone. Osteoclasts within lesions were larger and more nucleated than normal and some contained nuclear inclusions similar to those observed in human PDB. Osteoclast precursors from P394L mutant mice had increased sensitivity to RANKL in vitro resulting in the generation of osteoclasts that were larger and more nucleated than those generated from wild-type littermates. There was increased expression of sqstm1, autophagy-related gene 5 (atg5) and light chain 3 gene (lc3) in osteoclast precursors and increased LC3-II protein levels in Bafilomycin-treated osteoclasts from P394L mutant mice compared with wild-type suggesting dysregulation of autophagy and enhanced autophagosome formation. These studies demonstrate that SQSTM1 mutations can cause a PDB-like skeletal disorder in the absence of an additional trigger and provide a new disease model for PDB.

AB - Mutations of SQSTM1 occur in about 10% of patients with Paget's disease of bone (PDB), but it is unclear whether they play a causal role or regulate susceptibility to an environmental trigger. Here we show that mice with a proline to leucine mutation at codon 394 of mouse sqstm1 (P394L), equivalent to the P392L SQSTM1 mutation in humans, develop a bone disorder with remarkable similarity to PDB. The P394L mutant mice developed focal bone lesions with increasing age and by 12 months, 14/18 (77%) heterozygotes and 20/21 (95%) homozygotes had lesions, compared with 0/18 (0%) wild-type littermates (P < 0.001). Lesions predominantly affected the lower limbs in an asymmetric manner and were characterized by focal increases in bone turnover, with increased bone resorption and formation, disruption of the normal bone architecture and accumulation of woven bone. Osteoclasts within lesions were larger and more nucleated than normal and some contained nuclear inclusions similar to those observed in human PDB. Osteoclast precursors from P394L mutant mice had increased sensitivity to RANKL in vitro resulting in the generation of osteoclasts that were larger and more nucleated than those generated from wild-type littermates. There was increased expression of sqstm1, autophagy-related gene 5 (atg5) and light chain 3 gene (lc3) in osteoclast precursors and increased LC3-II protein levels in Bafilomycin-treated osteoclasts from P394L mutant mice compared with wild-type suggesting dysregulation of autophagy and enhanced autophagosome formation. These studies demonstrate that SQSTM1 mutations can cause a PDB-like skeletal disorder in the absence of an additional trigger and provide a new disease model for PDB.

UR - http://www.scopus.com/inward/record.url?scp=79959810997&partnerID=8YFLogxK

U2 - 10.1093/hmg/ddr172

DO - 10.1093/hmg/ddr172

M3 - Article

VL - 20

SP - 2734

EP - 2744

JO - Human Molecular Genetics

JF - Human Molecular Genetics

SN - 0964-6906

IS - 14

M1 - ddr172

ER -